Benzinga | Mar 15, 2021 04:02PM EDT

AcelRx Pharmaceuticals Q4 EPS $(0.10), Inline, Sales $738.00K Miss $1.73M Estimate

AcelRx Pharmaceuticals (NASDAQ:ACRX) reported quarterly losses of $(0.10) per share which met the analyst consensus estimate. This is a 44.44 percent increase over losses of $(0.18) per share from the same period last year. The company reported quarterly sales of $738.00 thousand which missed the analyst consensus estimate of $1.73 million by 57.34 percent. This is a 55.37 percent increase over sales of $475.00 thousand the same period last year.